AARTI PHARMALABS LIMITED

Scale -

PBT is 93.65 Rs Cr; Continuous Growth over 3 years; in Top Quartile; Annual Decline is -38 %
Quarterly Ebitda is 136 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile
Quarterly Profit is 68.74 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile
Revenue is 1819 Rs Cr; in Top Quartile; 5 Year CAGR is 11 %
Quarterly Revenue is 536 Rs Cr; in Top Quartile

Ebitda is 379 Rs Cr; Annual Decline is -20 %
PAT is 167 Rs Cr; Annual Decline is -39 %

Profitability -

Quarterly Ebitda Margin is 25 %; in Top Quartile

PAT Margin is 9.16 %; Annual Decline is -29 %

Return -

ROCE is 10.79 %; Annual Decline is -37 %
ROA is 5.01 %; Annual Decline is -47 %
ROE is 8.22 %; Annual Decline is -40 %
Asset Turnover is 57 %; Annual Decline is -26 %

Efficiency -

Inventory Turnover Ratio is 2.96; in Bottom Quartile

Solvancy -

Contingent Liabilities is 36.87 Rs Cr; Annual Decline is -55 %; 5 Year CAGR is -45 %

Debt/Equity is 0.32; Annual Growth is 60 %; Continuous Growth over 3 years
Long term Debt is 186 Rs Cr; Annual Growth is 79 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 329 %
Total Debt is 686 Rs Cr; Annual Growth is 73 %; Continuous Growth over 3 years; in Top Quartile

Quality -

Operating cashflow/PAT is 157 %; Annual Growth is 29 %; Continuous Growth over 3 years; in Top Quartile
Change in Inventories/Total Expenses is -3 %; Annual Decline is -188 %
Current Tax/PAT is 26 %; Continuous Decline over 3 years

Other Expenses/Total Expenses is 28 %; Annual Growth is 35 %; Continuous Growth over 3 years; 5 Year CAGR is 79 %

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: